1. Home
  2. USA vs LMAT Comparison

USA vs LMAT Comparison

Compare USA & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

USA

Liberty All-Star Equity Fund

HOLD

Current Price

$5.77

Market Cap

1.9B

Sector

Finance

ML Signal

HOLD

Logo LeMaitre Vascular Inc.

LMAT

LeMaitre Vascular Inc.

HOLD

Current Price

$99.54

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USA
LMAT
Founded
N/A
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.6B
IPO Year
1994
2006

Fundamental Metrics

Financial Performance
Metric
USA
LMAT
Price
$5.77
$99.54
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$105.80
AVG Volume (30 Days)
1.1M
201.6K
Earning Date
01-01-0001
05-05-2026
Dividend Yield
N/A
0.93%
EPS Growth
N/A
30.57
EPS
N/A
0.68
Revenue
N/A
$249,602,000.00
Revenue This Year
N/A
$14.21
Revenue Next Year
N/A
$8.88
P/E Ratio
N/A
$146.38
Revenue Growth
N/A
13.53
52 Week Low
$5.40
$78.35
52 Week High
$6.96
$118.01

Technical Indicators

Market Signals
Indicator
USA
LMAT
Relative Strength Index (RSI) 49.78 34.37
Support Level $5.71 $82.65
Resistance Level $5.88 $114.98
Average True Range (ATR) 0.06 5.27
MACD -0.01 -1.74
Stochastic Oscillator 38.89 19.42

Price Performance

Historical Comparison
USA
LMAT

About USA Liberty All-Star Equity Fund

Liberty All Star Equity Fund is a multi-managed fund. Its objective is to provide a high level of current income and long-term capital appreciation through investing principally in a diversified portfolio of equity securities. The fund invests in various sectors, including financials, information technology, healthcare, consumer discretionary, consumer staples, industrials, energy, materials, real estate, utilities, telecommunication, and other services.

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.

Share on Social Networks: